Uranium Royalty
Valuation each multiple against its own 5-year range
Vs. peers Uranium
| Company | Market cap | P/E (TTM)i | P/Bi | Div yieldi |
|---|---|---|---|---|
| Uranium Royalty (UROY) | 884.08M | 6.11 | 0.93 | 0.00% |
| Cameco (CCJ) | 25.26B | 91.34 | 5.01 | 0.29% |
| NexGen Energy (NXE) | 4.40B | -41.83 | 3.27 | 0.00% |
| Uranium Energy (UEC) | 2.63B | -18.93 | 1.91 | 0.00% |
| Centrus Energy (LEU) | 1.68B | 24.16 | 1.52 | 0.00% |
| Denison Mines (DNN) | 1.52B | -40.00 | 5.83 | 0.00% |
Other StockVane-tracked companies in the same industry.
Morningstar
Trading 72.4% below Morningstar's fair value estimate.
Fair value
Uranium Royalty Corp receives a 4-star quantitative star rating, illustrating our stance that this share class offers a somewhat attractive opportunity for investors. The stock currently trades at a 30% discount to our quantitative fair value estimate of $4.00 per share; however, caution is warranted due to this estimate's high uncertainty rating.
The firm's profitability increases our estimated valuation. Highly profitable companies are often more resilient in recessions and are likely to generate stronger future cash flows for shareholders. For example, the firm's earnings yield of 14.2% falls in the top 20% compared with peers globally. This suggests that it is generating substantial earnings relative to its share price, which contributes to our view that shares are undervalued.
The firm's valuation metrics are an additional encouraging factor. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. The firm's book value yield of 82.1%, for example, lies in the top 40% compared with peers globally. The market price is low relative to the book (accounting) value of the company's equity, which further promotes our favorable price/fair value ratio.
In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has outperformed the broader universe over the past year. This outperformance bodes well for future returns in light of other contributors to our model.
Economic moat
This company lacks a competitive advantage, receiving a quantitative economic moat rating of none. Additionally, the firm's moderate financial health score suggests it is acceptably positioned against adverse economic circumstances.
By Quantitative Equity Report
Quote time 2026-11-20 20:02:37 · For reference only, not investment advice and not tailored to your situation.
Uranium Royalty discussion 0 comments